FIL Limited 13D and 13G filings for BioXcel Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-10-10 09:09 am Purchase | 2023-10-09 | 13G | BioXcel Therapeutics, Inc. BTAI | FIL Limited | 2,700,727 9.227% | 2,700,727 (New Position) | Filing |